Sofpironium Bromide Gel Promising for Primary Axillary Hyperhidrosis
Sofpironium bromide is a structural analogue of glycopyrrolate, an anticholinergic agent.
Sofpironium bromide is a structural analogue of glycopyrrolate, an anticholinergic agent.
The safety, tolerability, and efficacy of sofpironium bromide gel for the treatment of primary axillary hyperhidrosis was evaluated.
The effectiveness of oral oxybutynin in hyperhidrosis, besides its tolerance and safety, was evaluated in a real-life study.
Evidence regarding the treatment approaches and outcomes associated with abobotulinumtoxinA (aboBoNT-A) treatment of hyperhidrosis were identified in a review study.
A review provides an update on current and emerging concepts of management for excessive hand sweating to help clinicians optimize therapeutic decision making.
Positive correlations found between the number of anatomical sites involved in hyperhidrosis and the prevalence of psychiatric conditions.
Hyperhidrosis was more prevalent among both men and women who were obese compared with those of normal weight.
Newly approved treatment options for axillary hyperhidrosis give more opportunities for clinicians to provide personalized treatment for patients.
A single cloth should be used to apply Qbrexza to both underarms.
Topical once-daily glycopyrronium tosylate appears to provide a noninvasive, well-tolerated treatment option for patients with primary axillary hyperhidrosis.